

( (S (NP-SBJ-2 Medical scientists)
     (VP are
         (VP starting
             (S (NP-SBJ *-2)
                (VP to
                    (VP uncover
                        (NP (NP a handful)
                            (PP of
                                (NP (NP genes)
                                    (SBAR (WHNP-3 which)
                                          (S (NP-SBJ-4 *T*-3)
					     (PRN ,
						  (SBAR-ADV if
							    (S (NP-SBJ-5 *-4)
							       (VP damaged
								   (NP *-5))))
						  ,)
                                             (VP unleash
                                                 (NP (NP the chaotic growth)
                                                     (PP of
                                                         (NP cells))
						     (SBAR (WHNP-1 that)
							   (S (NP-SBJ *T*-1)
							      (VP characterizes
								  (NP cancer))))))))))))))))
     .))
( (S (NP-SBJ Scientists)
     (VP say
         (SBAR 0
               (S (NP-SBJ (NP the discovery)
                          (PP of
                              (NP these genes))
                          (PP-TMP in
				  (NP recent months)))
                  (VP is
                      (VP painting
                          (NP (NP a (ADJP new and startling) picture)
                              (PP of
                                  (SBAR-NOM (WHADVP-1 how)
					    (S (NP-SBJ cancer)
					       (VP develops
						   (ADVP-MNR *T*-1)))))))))))
     .))
( (S (NP-SBJ-1 (NP An emerging understanding)
	       (PP of
		   (NP the genes)))
     (VP is
         (VP expected
             (S (NP-SBJ *-1)
                (VP to
                    (VP produce
                        (NP (NP an array)
                            (PP of
                                (NP (NP new strategies)
                                    (PP for
                                        (NP future cancer treatment and prevention))))))))))
     .))
( (S (NP-SBJ That)
     (VP is
         (PP-PRD for
		 (NP the future)))
     .))
( (S (ADVP-TMP Already)
     ,
     (NP-SBJ scientists)
     (VP are
         (VP developing
             (NP (NP tests)
		 (VP based
		     (NP *)
		     (PP-CLR on
			     (NP the
				 (ADJP newly identified)
				 genes)))
                 (SBAR (WHNP-1 that)
                       (S (NP-SBJ *T*-1)
                          ,
                          (PP-TMP for
				  (NP the first time))
                          ,
                          (VP can
                              (VP predict
                                  (SBAR whether
                                        (S (NP-SBJ-2 an
						     (ADJP otherwise healthy)
						     individual)
                                           (VP is
                                               (ADJP-PRD likely
							 (S (NP-SBJ *-2)
							    (VP to
								(VP get
								    (NP cancer)))))))))))))))
     .))
( (SINV ``
	(S-TPC-2 (NP-SBJ It)
		 (VP 's
		     (NP-PRD (NP a super-exciting set)
			     (PP of
				 (NP discoveries)))))
	,
	''
	(VP says
	    (S *T*-2))
	(NP-SBJ (NP Bert Vogelstein)
		,
		(NP (NP a Johns Hopkins University researcher)
		    (SBAR (WHNP-1 who)
			  (S (NP-SBJ *T*-1)
			     (VP has
				 (ADVP just)
				 (VP found
				     (NP (NP a gene)
					 (ADJP pivotal
					       (PP to
						   (NP (NP the triggering)
						       (PP of
							   (NP colon cancer))))))))))))
	.))
( (S ``
     (ADVP-TMP (NP Only a decade)
	       ago)
     (NP-SBJ cancer)
     (VP was
	 (NP-PRD (NP a black box)
		 (SBAR (WHPP-1 about
			       (WHNP which))
		       (S (NP-SBJ we)
			  (VP knew
			      (NP nothing)
			      (PP-CLR *T*-1)
			      (PP at
				  (NP the molecular level)))))))
     .))
( (S (NP-TMP Today)
     ,
     (NP-SBJ we)
     (VP know
         (SBAR that
               (S (NP-SBJ (NP the accumulation)
                          (PP of
                              (NP (NP several)
                                  (PP of
                                      (NP these altered genes)))))
                  (VP can
                      (VP (VP initiate
                              (NP a cancer))
                          and
			  (PRN ,
			       (ADVP then)
			       ,)
			  (VP propel
                              (NP it)
                              (PP-CLR into
				      (NP a deadly state))))))))
     . ''))
( (S (NP-SBJ Scientists)
     (VP call
         (S (NP-SBJ (NP the new class)
		    (PP of
			(NP genes)))
	    (NP-PRD (NP tumor-suppressors)
		    (PRN ,
			 or
			 (ADVP simply)
			 (NP anti-cancer genes)))))
     .))
( (S (SBAR-TMP (WHADVP-2 When)
	       (S (NP-SBJ *-3)
		  (VP functioning
		      (ADVP-MNR normally)
		      (ADVP-TMP *T*-2))))
     ,
     (NP-SBJ-3 they)
     (VP make
         (NP (NP proteins)
             (SBAR (WHNP-1 that)
                   (S (NP-SBJ *T*-1)
                      (VP hold
                          (NP (NP a cell 's)
                              growth)
                          (PP-CLR in
				  (NP check)))))))
     .))
( (S But
     (SBAR-ADV if
	       (S (NP-SBJ-1 the genes)
		  (VP are
		      (VP damaged
			  (NP *-1)
			  (PRN --
			       (PP-MNR perhaps
				       (PP by
					   (NP (NP radiation)
					       ,
					       (NP a chemical)))
				       or
				       (PP through
					   (NP (NP a chance accident)
					       (PP in
						   (NP cell division)))))
			       --)))))
     (S (NP-SBJ their growth-suppressing proteins)
        (ADVP-TMP no longer)
	(VP work))
     , and
     (S (NP-SBJ (NP cells)
		(PP (ADVP normally)
		    under
                    (NP control)))
        (VP turn
            (ADJP-PRD malignant)))
     .))
( (S (NP-SBJ The
             (ADJP newly identified)
             genes)
     (VP differ
         (PP-CLR from
		 (NP (NP a family)
		     (PP of
			 (NP (NP genes)
			     (VP discovered
				 (NP *)
				 (PP-TMP in
					 (NP the early 1980s)))))
		     (VP called
			 (S (NP-SBJ *)
			    (NP-PRD oncogenes))))))
     .))
( (S (S (NP-SBJ Oncogenes)
        (VP must
            (VP be
                (ADJP-PRD present)
                (SBAR-PRP for
			  (S (NP-SBJ a cell)
			     (VP to
				 (VP become
				     (ADJP-PRD malignant))))))))
     , but
     (S (NP-SBJ researchers)
	(VP have
	    (VP found
		(NP them)
		(PP-LOC (PP in
			    (NP normal
				(NX *RNR*-1)))
			(CONJP as well as)
			(PP in
			    (NP cancerous
				(NX *RNR*-1)))
			(NX-1 cells))
		,
		(S-ADV (NP-SBJ *)
		       (VP suggesting
			   (SBAR that
				 (S (NP-SBJ oncogenes)
				    (VP do n't
					(VP cause
					    (NP cancer)
					    (PP by
						(NP themselves)))))))))))
     .))
( (S (PP-TMP In
	     (NP recent months))
     ,
     (NP-SBJ-2 researchers)
     (VP have
         (VP come
             (S (NP-SBJ *-2)
                (VP to
                    (VP believe
                        (SBAR 0
                              (S (S (NP-SBJ (NP the two types)
                                            (PP of
                                                (NP cancer genes)))
                                    (VP work
                                        (PP-MNR in
						(NP concert))))
                                 :
                                 (S (NP-SBJ An oncogene)
                                    (VP may
                                        (VP turn
                                            (S (NP-SBJ proliferating
						       cells)
					       (ADJP-PRD malignant))
					    (SBAR-TMP only after
						      (S (NP-SBJ-1 the tumor-suppressor gene)
							 (VP has
							     (VP been
								 (VP damaged
								     (NP *-1))))))))))))))))
     .))
( (S (PP Like
         (NP all genes))
     ,
     (NP-SBJ-1 tumor-suppressor genes)
     (VP are
         (VP inherited
             (NP *-1)
             (PP-MNR in
		     (NP (NP two copies)
			 ,
			 (NP (NP one)
			     (PP from
				 (NP each parent)))))))
     .))
( (S (S (NP-SBJ Either copy)
        (VP can
            (VP make
                (NP (NP the proteins)
                    (VP needed
			(NP *)
			(S-PRP (NP-SBJ *)
			       (VP to
				   (VP control
				       (NP cell growth)))))))))
     ,
     so
     (S (SBAR-PRP for
		  (S (NP-SBJ cancer)
		     (VP to
			 (VP arise))))
        ,
        (NP-SBJ both copies)
        (VP must
            (VP be
                (ADJP-PRD impaired))))
     .))
( (S (NP-SBJ (NP A person)
	     (SBAR (SBAR (WHNP-3 who)
			 (S (NP-SBJ-1 *T*-3)
			    (VP is
				(VP born
				    (NP *-1)
				    (PP with
					(NP (NP one defective copy)
					    (PP of
						(NP a suppressor gene))))))))
		   , or
		   (SBAR (WHPP-4 in
				 (WHNP whom))
			 (S (NP-SBJ-2 one copy)
			    (VP is
				(VP damaged
				    (NP *-2)
				    (ADVP-TMP early
					      (PP in
						  (NP life)))
				    (PP-LOC *T*-4)))))
		   ,))
     (VP is
	 (ADJP-PRD especially prone
		   (PP to
		       (NP cancer)))
	 (SBAR-PRP because
		   (S (NP-SBJ-5 he)
		      (VP need
			  (ADVP only)
			  (S (NP-SBJ *-5)
			     (VP lose
				 (NP the other copy)))
			  (SBAR-PRP for
				    (S (NP-SBJ a cancer)
				       (VP to
					   (VP develop))))))))
     .))
( (S (NP-SBJ-1 Emerging
	       genetic tests)
     (VP will
         (VP be
             (ADJP-PRD able
		       (S (NP-SBJ *-1)
			  (VP to
			      (VP spot
				  (NP such cancer-susceptible individuals)))))
	     ,
	     (S-ADV (NP-SBJ *)
		    (VP ushering
			(PRT in)
			(SBAR-NOM (WHNP-2 what)
				  (S (NP-SBJ some scientists)
				     (VP believe
					 (SBAR 0
					       (S (NP-SBJ *T*-2)
						  (VP is
						      (NP-PRD (NP a new age)
							      (PP of
								  (NP predictive cancer diagnosis)))))))))))))
     .))
( (S (NP-SBJ Bill and Bonnie Quinlan)
     (VP are
         (PP-PRD among
		 (NP (NP the first beneficiaries)
		     (PP of
			 (NP the new findings)))))
     .))
( (S (NP-SBJ The
             (NAC-LOC Dedham
		      ,
		      Mass.
		      ,)
             couple)
     (VP knew
         (SBAR-TMP even before
		   (S (NP-SBJ Bonnie)
		      (VP became
			  (ADJP-PRD pregnant)
			  (PP-TMP in
				  (NP 1987)))))
	 (SBAR that
	       (S (NP-SBJ (NP any child)
			  (PP of
			      (NP theirs)))
		  (VP had
		      (NP (NP a (ADJP 50 %) chance)
			  (PP of
			      (S-NOM (NP-SBJ *)
				     (VP being
					 (PP-PRD at
						 (NP (NP risk)
						     (PP for
							 (NP (NP retinoblastoma)
							     ,
							     (NP (NP an eye cancer)
								 (SBAR (WHNP-1 that)
								       (S (NP-SBJ *T*-1)
									  (VP occurs
									      (NP-TMP about once)
									      (NP-TMP every 20,000 births)))))))))))))))))
     .))
( (S (NP-SBJ-3 (NP Mr. Quinlan)
	       ,
	       (ADJP (NP 30 years)
		     old)
	       ,)
     (VP knew
	 (SBAR 0
	       (S (NP-SBJ he)
		  (VP carried
		      (NP a damaged gene))))
	 ,
	 (S-ADV (NP-SBJ *-3)
		(VP having
		    (VP lost
			(NP an eye)
			(PP-CLR to
				(NP the rare tumor))
			(SBAR-TMP (WHADVP-1 when)
				  (S (NP-SBJ he)
				     (VP was
					 (ADJP-PRD (NP only two months)
						   old)
					 (ADVP-TMP *T*-1))))
			--
			(SBAR-TMP after
				  (S (NP-SBJ his mother)
				     (VP had
					 (VP suffered
					     (NP the same fate)
					     (SBAR-TMP (WHADVP-2 when)
						       (S (NP-SBJ she)
							  (VP was
							      (NP-PRD a baby)
							      (ADVP-TMP *T*-2))))))))))))
     .))
( (S (PP-PRP Because of
	     (NP (NP the isolation)
		 (PP of
		     (NP the retinoblastoma tumor-suppressor gene))))
     ,
     (NP-SBJ (NP it)
	     (S *EXP*-1))
     (VP became
         (ADJP-PRD possible)
         (NP-TMP last January)
         (S-1 (NP-SBJ *)
              (VP to
		  (VP find
		      (PRT out)
		      (SBAR (WHNP-2 what threat)
			    (S (NP-SBJ the Quinlan baby)
			       (VP faced
				   (NP *T*-2))))))))
     .))
( (S (NP-SBJ (NP A test)
             (VP using
                 (NP new `` genetic probes '')))
     (VP showed
         (SBAR that
               (S (NP-SBJ little Will Quinlan)
                  (VP had not
                      (VP (VP inherited
                              (NP a damaged retinoblastoma supressor gene))
                          and
			  (PRN ,
			       (ADVP therefore)
			       ,)
			  (VP faced
                              (NP (NP (ADJP no more)
				      risk)
                                  (PP than
                                      (NP other children))
                                  (PP of
                                      (S-NOM (NP-SBJ *)
					     (VP developing
						 (NP the rare cancer)))))))))))
     .))
( (SINV ``
	(S-TPC-1 (NP-SBJ It)
		 (VP made
		     (NP our New Year)))
	,
	''
	(VP says
	    (S *T*-1))
	(NP-SBJ Mr. Quinlan)
	.))
( (S (NP-SBJ This test)
     (VP was
         (NP-PRD (NP the first)
		 (SBAR (WHNP-2 0)
		       (S (NP-SBJ *T*-2)
			  (VP to
			      (VP predict
				  (ADVP-MNR reliably)
				  (SBAR whether
					(S (NP-SBJ-1 an individual)
					   (VP could
					       (VP expect
						   (S (NP-SBJ *-1)
						      (VP to
							  (VP develop
							      (NP cancer))))))))))))))
     .))
( (S (ADVP Equally important)
     ,
     (NP-SBJ (NP the initial discovery)
	     (PP of
		 (NP (NP the gene)
		     (SBAR (WHNP-1 that)
			   (S (NP-SBJ *T*-1)
			      (VP controls
				  (NP retinal cell growth))))))
	     ,
	     (VP made
		 (NP *)
		 (PP by
		     (NP-LGS (NP a Boston doctor)
			     (VP named
				 (S (NP-SBJ *)
				    (NP-PRD Thaddeus Dryja))))))
	     ,)
     (VP has
	 (VP opened
	     (NP (NP a field)
		 (PP of
		     (NP cancer study))
		 ,
		 (SBAR (WHNP-2 which)
		       (S (NP-SBJ *T*-2)
			  (PP-TMP in
				  (NP recent months))
			  (VP has
			      (VP exploded)))))))
     .))
( (SINV ``
	(S-TPC-1 (NP-SBJ It)
		 (VP turns
		     (PRT out)
		     (SBAR that
			   (S (S-NOM-SBJ (NP-SBJ *)
					 (VP studying
					     (NP a
						 (ADJP tragic but uncommon)
						 tumor)))
			      (VP made
				  (S (ADJP-PRD possible)
				     (NP-SBJ (NP some fundamental insights)
					     (PP about
						 (NP (NP the
							 (ADJP most basic)
							 workings)
						     (PP of
							 (NP cancer)))))))))))
	,
	''
	(VP says
	    (S *T*-1))
	(NP-SBJ (NP Samuel Broder)
		,
		(NP (NP director)
		    (PP of
			(NP the National Cancer Institute))))
	.))
( (S ``
     (S (NP-SBJ All this)
	(VP may not
	    (VP be
		(ADJP-PRD obvious
			  (PP to
			      (NP (NP the public)
				  ,
				  (SBAR (WHNP-1 which)
					(S (NP-SBJ *T*-1)
					   (VP is
					       (ADJP-PRD concerned
							 (PP about
							     (NP (NP advances)
								 (PP in
								     (NP treatment))))))))))))))
     , but
     (S (NP-SBJ I)
	(VP am
	    (ADJP-PRD convinced
		      (SBAR 0
			    (S (NP-SBJ-2 this basic research)
			       (VP will
				   (VP begin
				       (S (NP-SBJ *-2)
					  (VP showing
					      (NP results)
					      (ADVP-LOC there)
					      (ADVP-TMP soon))))))))))
     . ''))
( (S (PP-TMP To
	     (NP date))
     ,
     (NP-SBJ scientists)
     (VP have
         (VP fingered
             (NP (NP two)
                 (PP of
                     (NP these cancer-suppressors)))))
     .))
( (S (NP-SBJ Dr. Dryja)
     (VP made
         (NP his retinoblastoma discovery)
         (PP-TMP in
		 (NP 1986)))
     .))
( (S (ADVP Then)
     (NP-TMP last spring)
     ,
     (NP-SBJ-2 researchers)
     (VP reported
         (S (NP-SBJ *-2)
            (VP finding
                (NP (NP a gene)
                    (VP called
                        (S (NP-SBJ *)
			   (NP-PRD p53)))
		    (SBAR (WHNP-1 which)
			  (S (NP-SBJ-3 *T*-1)
			     (PRN ,
				  (SBAR-ADV if
					    (S (NP-SBJ-4 *-3)
					       (VP impaired
						   (NP *-4))))
				  ,)
			     (VP turns
				 (S (NP-SBJ healthy colon cells)
				    (ADJP-PRD cancerous)))))))))
     .))
( (S (PP-TMP Soon after 
	     (NP that report))
     ,
     (NP-SBJ two other research teams)
     (VP uncovered
         (NP evidence
             (SBAR that
                   (S (NP-SBJ the same damaged p53 gene)
                      (VP is
                          (ADJP-PRD present
				    (PP-LOC in
					    (NP (NP tissue)
						(PP from
						    (NP lung and breast cancers))))))))))
     .))
( (S (NP-SBJ Colon , lung and breast cancers)
     (VP are
         (NP-PRD (NP the
		     (ADJP most common and lethal)
		     forms)
		 (PP of
		     (NP the disease))
		 ,
		 (VP (ADVP collectively)
		     killing
		     (NP (NP (QP almost 200,000)
			     Americans)
			 (NP-ADV a year)))))
     .))
( (S (ADVP-TMP Right now)
     (NP-SBJ-1 (NP (QP about a dozen) laboratories)
	       ,
	       (PP-LOC in
		       (NP (NP the U.S.)
			   ,
			   (NP Canada)
			   and
			   (NP Britain)))
	       ,)
     (VP are
         (VP racing
             (S (NP-SBJ *-1)
                (VP to
                    (VP unmask
                        (NP other suspected tumor-suppressing genes))))))
     .))
( (S (NP-SBJ They)
     (VP have
         (NP (QP about seven)
             candidates))
     .))
( (S (NP-SBJ Researchers)
     (VP say
         (SBAR 0
               (S (NP-SBJ (NP the inactivation)
                          (PP of
                              (NP tumor-suppressor genes))
                          ,
                          (UCP (ADVP alone)
			       or
			       (PP in
				   (NP combination)))
                          ,)
                  (VP appears
                      (ADJP-PRD crucial
				(PP to
				    (NP (NP the development)
					(PP of
					    (NP (NP such scourges)
						(PP as
						    (NP (NP cancer)
							(PP of
							    (NP (NP the brain)
								,
								(NP the skin)
								,
								(NP kidney)
								,
								(NP prostate)
								,
								and
								(NP cervix))))))))))))))
     .))
( (S (NP-SBJ There)
     (VP is
         (NP-PRD evidence
		 (SBAR that
		       (S (SBAR-ADV if
				    (S (NP-SBJ people)
				       (VP inherit
					   (NP (NP defective versions)
					       (PP of
						   (NP these genes))))))
			  ,
			  (NP-SBJ they)
			  (VP are
			      (ADJP-PRD especially prone
					(PP to
					    (NP cancer)))
			      ,
			      (S-ADV (NP-SBJ *)
				     (ADVP perhaps)
				     (VP explaining
					 ,
					 (ADVP finally)
					 ,
					 (SBAR (WHADVP-1 why)
					       (S (NP-SBJ-2 some cancers)
						  (VP seem
						      (S (NP-SBJ *-2)
							 (VP to
							     (VP haunt
								 (NP certain families)
								 (ADVP-PRP *T*-1))))))))))))))
     .))
( (S (NP-SBJ (NP The story)
             (PP of
                 (NP tumor-suppressor genes)))
     (VP goes
         (ADVP-CLR back
		   (PP to
		       (NP (NP the 1970s)
			   ,
			   (SBAR-TMP (WHADVP-1 when)
				     (S (NP-SBJ (NP a pediatrician)
						(VP named
						    (S (NP-SBJ *)
						       (NP-PRD Alfred G. Knudson Jr.))))
					(VP proposed
					    (SBAR that
						  (S (NP-SBJ retinoblastoma)
						     (VP stemmed
							 (PP-CLR from
								 (NP two separate genetic defects)))))
					    (ADVP-TMP *T*-1))))))))
     .))
( (S (NP-SBJ He)
     (VP theorized
         (SBAR that
               (S (PP-LOC in
			  (NP the eye cancer))
                  ,
                  (NP-SBJ an infant)
                  (VP (VP inherited
			  (NP-1 (NP a damaged copy)
				(PP of
				    (NP a gene)))
			  (PP-CLR-2 from
				    (NP one parent)))
		      and
		      (VP (NP=1 a normal copy)
			  (PP-CLR=2 from
				    (NP the other)))))))
     .))
( (S-2 (NP-SBJ The tumor)
       (PRN ,
	    (S (NP-SBJ he)
	       (VP suggested
		   (SBAR 0
			 (S *T*-2))))
	    ,)
       (VP developed
	   (SBAR-TMP (WHADVP-3 when)
		     (S (NP-SBJ-1 the second , normal copy)
			(ADVP also)
			(VP was
			    (VP damaged
				(NP *-1)
				(ADVP-TMP *T*-3))))))
       .))
( (S But
     (NP-SBJ there)
     (VP was
         (NP-PRD (NP no way)
		 (SBAR (WHADVP-1 0)
		       (S (NP-SBJ *)
			  (VP to
			      (VP prove
				  (NP (NP Dr. Knudson 's)
				      `` two-hit '' theory)
				  (ADVP-MNR *T*-1)))))))
     .))
( (S (ADVP-TMP Back then)
     ,
     (S (NP-SBJ scientists)
        (VP had
            (NP (NP no way)
                (PP of
                    (S-NOM (NP-SBJ *)
			   (VP ferreting
			       (PRT out)
			       (NP specific genes)))))))
     , but
     (S (PP-LOC under
		(NP a microscope))
        (NP-SBJ they)
        (VP could
            (VP see
                (NP (NP the 23 pairs)
                    (PP of
                        (NP chromosomes))
		    (PP-LOC in
			    (NP (NP the cells)
				(SBAR (WHNP-1 that)
				      (S (NP-SBJ *T*-1)
					 (VP contain
					     (NP the genes))))))))))
     .))
( (S (ADVP-TMP Occasionally)
     ,
     (NP-SBJ gross chromosome damage)
     (VP was
         (ADJP-PRD visible))
     .))
( (S (NP-SBJ Dr. Knudson)
     (VP found
         (SBAR that
               (S (NP-SBJ (NP some children)
                          (PP with
                              (NP the eye cancer)))
                  (VP had
                      (VP inherited
                          (NP (NP a damaged copy)
                              (PP of
                                  (NP chromosome No. 13)))
                          (PP-CLR from
				  (NP (NP a parent)
				      (SBAR (WHNP-1 who)
					    (S (NP-SBJ *T*-1)
					       (VP had
						   (VP had
						       (NP the disease))))))))))))
     .))
( (S (PP-LOC Under
	     (NP a microscope))
     (NP-SBJ he)
     (VP could
         (ADVP actually)
	 (VP see
             (SBAR that
                   (S (NP-SBJ (NP a bit)
                              (PP of
                                  (NP chromosome 13)))
                      (VP was
                          (ADJP-PRD missing))))))
     .))
( (S (NP-SBJ He)
     (VP assumed
         (SBAR 0
               (S (NP-SBJ the missing piece)
                  (VP contained
                      (NP (NP (NP a gene)
                              or
                              (NP genes))
                          (SBAR (WHNP-1 whose loss)
                                (S (NP-SBJ *T*-1)
                                   (VP had
                                       (NP (NP a critical role)
                                           (PP-LOC in
						   (S-NOM (NP-SBJ *)
							  (VP setting
							      (PRT off)
							      (NP the cancer)))))))))))))
     .))
( (S But
     (NP-SBJ he)
     (VP did n't
         (VP know
             (SBAR (WHNP-1 which gene or genes)
                   (S (NP-SBJ *T*-1)
                      (VP had
                          (VP disappeared))))))
     .))
( (S (ADVP-TMP Then)
     ,
     (NP-SBJ (NP a scientific team)
             (VP led
                 (NP *)
                 (PP by
                     (NP-LGS (NP molecular geneticist
                                 Webster Cavenee)
                             (PRN ,
				  (ADVP-TMP then) 
				  (PP-LOC at
					  (NP (NP the University)
					      (PP of
						  (NP Utah))))
				  ,)))))
     (VP found
         (NP the answer))
     .))
( (S (NP-SBJ The team)
     (VP used
         (NP (NP a battery)
             (PP of
                 (NP (NP the
                         (ADJP newly developed)
			 `` gene probes)
		     ,
		     ''
                     (NP (NP snippets)
			 (PP of
			     (NP genetic material))
                         (SBAR (WHNP-1 that)
                               (S (NP-SBJ *T*-1)
                                  (VP can
                                      (VP track
                                          (NP (NP a gene 's)
                                              presence)
					  (PP-LOC in
						  (NP a cell)))))))))))
     .))
( (S (PP-MNR By
	     (S-NOM (NP-SBJ *-1)
		    (VP analyzing
			(NP (NP cells)
			    (VP extracted
				(NP *)
				(PP-CLR from
					(NP eye tumors)))))))
     ,
     (NP-SBJ-1 they)
     (VP found
         (NP (NP defects)
	     (PP-LOC in
		     (NP (NP the second copy)
			 (PP of
			     (NP chromosome 13)))))
	 (PP-LOC-CLR in
		     (NP (NP the exact area)
			 (PP as
			     (PP in
				 (NP (NP the first copy)
				     (PP of
					 (NP the chromosome))))))))
     .))
( (S (NP-SBJ The finding)
     (VP riveted
         (NP medicine))
     .))
( (S (NP-SBJ It)
     (VP was
         (NP-PRD (NP the first time)
		 (SBAR (WHADVP-1 0)
		       (S (NP-SBJ anyone)
			  (VP had
			      (VP showed
				  (SBAR that
					(S (NP-SBJ (NP the loss)
						   (PP of
						       (NP (NP both copies)
							   (PP of
							       (NP the same gene)))))
					   (VP could
					       (VP lead
						   (PP-CLR to
							   (NP (NP the eruption)
							       (PP of
								   (NP a cancer))))))))
				  (ADVP-TMP *T*-1)))))))
     .))
( (SINV ``
	(S-TPC-1 (NP-SBJ It)
		 (VP was
		     (ADJP-PRD extraordinarily satisfying)))
	,
	''
	(VP says
	    (S *T*-1))
	(NP-SBJ (NP Dr. Knudson)
		(PRN ,
		     (ADVP-TMP now) 
		     (PP-LOC at
			     (NP (NP Fox Chase Cancer Research Center)
				 (PP-LOC in
					 (NP Philadelphia))))))
	.))
( (S ``
     (NP-SBJ I)
     (VP was
         (ADJP-PRD convinced
		   (SBAR that
			 (S (SBAR-NOM-SBJ (WHNP-1 what)
					  (S (NP-SBJ *T*-1)
					     (VP was
						 (ADJP-PRD true
							   (PP of
							       (NP retinoblastoma))))))
			    (VP would
				(VP be
				    (ADJP-PRD true
					      (PP for
						  (NP all cancers)))))))))
     . ''))
( (S (NP-SBJ It)
     (VP was
         (NP-PRD an audacious claim))
     .))
( (S But
     (PP-LOC in
	     (NP Baltimore))
     ,
     (NP-SBJ-1 (NP Dr. Vogelstein)
	       ,
	       (NP (NP a young molecular biologist)
		   (PP-LOC at
			   (NP Johns Hopkins Medical School)))
	       ,)
     (VP (VP believed
             (SBAR 0
                   (S (NP-SBJ Dr. Knudson)
                      (VP was
                          (ADJP-PRD right)))))
         , and
         (VP set
             (PRT out)
             (S (NP-SBJ *-1)
                (VP to
                    (VP repeat
                        (NP the Cavenee experiment)
                        (PP-LOC in
				(NP (NP cells)
				    (PP from
					(NP other cancers)))))))))
     .))
( (S (NP-SBJ His)
     (VP was
         (NP-PRD (NP one)
		 (PP of
		     (NP two research teams))
		 (PP-TMP in
			 (NP 1984))
		 (SBAR (WHNP-2 0)
		       (S (NP-SBJ *T*-2)
			  (VP to
			      (VP report
				  (NP dual chromosome losses)
				  (PP-CLR for
					  (NP (NP a rare childhood cancer)
					      (PP of
						  (NP the kidney))
					      (VP called
						  (S (NP-SBJ *)
						     (NP-PRD (NP Wilm 's)
							     tumor)))))))))))
     .))
( (S (NP-SBJ Dr. Vogelstein)
     (ADVP-TMP next)
     (VP turned
         (NP his attention)
         (PP-CLR to
		 (NP (NP colon cancer)
		     ,
		     (NP (NP the
			     (ADJP second biggest)
			     cancer killer)
			 (PP-LOC in
				 (NP the U.S.))
			 (PP after
			     (NP lung cancer))))))
     .))
( (S (NP-SBJ He)
     (VP believed
	 (SBAR 0
	       (S (NP-SBJ colon cancer)
		  (VP might
		      (ADVP also)
		      (VP arise
			  (PP-CLR from
				  (NP (NP multiple `` hits '')
				      (PP on
					  (NP cancer suppressor genes))))
			  ,
			  (SBAR-PRP because
				    (S (NP-SBJ-1 it)
				       (ADVP-TMP often)
				       (VP seems
					   (S (NP-SBJ *-1)
					      (VP to
						  (VP develop
						      (PP-MNR in
							      (NP stages)))))))))))))
     .))
( (S (NP-SBJ-1 It)
     (ADVP-TMP often)
     (VP is
         (VP preceded
             (NP *-1)
             (PP by
                 (NP-LGS (NP the development)
			 (PP of
			     (NP (NP polyps)
				 (PP-LOC in
					 (NP the bowel))
				 ,
				 (SBAR (WHNP-2 which)
				       (S (NP-SBJ-3 *T*-2)
					  (PP-LOC in
						  (NP some cases))
					  (VP become
					      (ADJP-PRD increasingly malignant)
					      (PP-MNR in
						      (NP identifiable stages))
					      (PRN --
						   (S-ADV (NP-SBJ *-3)
							  (VP progressing
							      (PP-CLR from
								      (ADJP less severe))
							      (PP-CLR to
								      (ADJP deadly))))
						   --)
					      (SBAR-ADV as though
							(S (NP-SBJ (NP a cascade)
								   (PP of
								       (NP genetic damage)))
							   (VP might
							       (VP be
								   (VP occurring))))))))))))))
     .))
( (S (NP-SBJ-1 (NP Dr. Vogelstein)
	       and
	       (NP (NP a doctoral student)
		   ,
		   (NP Eric Fearon)
		   ,))
     (VP began
         (NP-TMP (NP months)
		 (PP of
		     (NP (NP (ADJP (ADJP tedious)
				   and
				   (ADJP often frustrating)) 
			     probing)
			 (PP of
			     (NP the chromosomes)))))
         (S-ADV (NP-SBJ *-1)
		(VP searching
		    (PP-CLR for
			    (NP (NP signs)
				(PP of
				    (NP genetic damage)))))))
     .))
( (S (NP-SBJ-1 They)
     (VP began
         (S (NP-SBJ *-1)
	    (VP uncovering
		(NP (NP a confusing variety)
		    (PP of
			(NP (NP genetic deletions)
			    ,
			    (NP (NP (NP some)
				    (VP existing
					(ADVP only)
					(PP-LOC in
						(NP benign polyps))))
				,
				(NP (NP others)
				    (PP-LOC in
					    (NP malignant cells)))
				and
				(NP (NP many)
				    (PP-LOC in
					    (NP both
						(NP polyps)
						and
						(NP malignant cells)))))))))))
     .))
( (S (ADVP-MNR Gradually)
     ,
     (NP-SBJ (NP a coherent picture)
             (PP of
                 (NP cancer development)))
     (VP emerged)
     .))
( (S (SBAR-ADV If
	       (S (NP-SBJ (NP both copies)
			  (PP of
			      (NP a certain gene)))
		  (VP were
		      (VP knocked
			  (PRT out)))))
     ,
     (NP-SBJ benign polyps)
     (VP would
         (VP develop))
     .))
( (S (SBAR-ADV If
	       (S (NP-SBJ-1 (NP both copies)
			    (PP of
				(NP a second gene)))
		  (VP were
		      (ADVP-TMP then)
		      (VP deleted
			  (NP *-1)))))
     ,
     (NP-SBJ the polyps)
     (VP would
         (VP progress
             (PP-CLR to
		     (NP malignancy))))
     .))
( (S (NP-SBJ (NP It)
	     (SBAR *EXP*-3))
     (VP was
         (ADJP-PRD clear)
	 (SBAR-3 that
		 (S (NP-SBJ-2 (QP more than one)
			      gene)
		    (VP had
			(S (NP-SBJ-1 *-2)
			   (VP to
			       (VP be
				   (VP damaged
				       (NP *-1)))))
			(SBAR-PRP for
				  (S (NP-SBJ colon cancer)
				     (VP to
					 (VP develop))))))))
     .))
( (S (NP-SBJ Their report)
     (VP galvanized
         (NP other molecular biologists))
     .))
((SINV ``
       (S-TPC-3 (NP-SBJ It)
		(VP was
		    (NP-PRD (NP the confirming evidence
				(SBAR *ICH*-2))
			    (SBAR (WHNP-1 0)
				  (S (NP-SBJ (NP we)
					     (NP all))
				     (VP needed
					 (NP *T*-1))))
			    (SBAR-2 that
				    (S (NP-SBJ -LCB- gene -RCB- losses)
				       (VP were
					   (ADJP-PRD critical
						     (PP to
							 (NP (NP the development)
							     (PP of
								 (NP a common tumor)))))))))))
       ,
       ''
       (VP says
	   (S *T*-3))
       (NP-SBJ (NP Ray White)
	       (PP-LOC at
		       (NP (NP Howard Hughes Medical Institute)
			   (PP-LOC in
				   (NP Salt Lake City)))))
       .))
( (S But
     (NP-SBJ-2 Dr. Vogelstein)
     (VP had
         (ADVP yet)
         (S (NP-SBJ *-2)
            (VP to
                (VP nail
                    (NP (NP the identity)
                        (PP of
                            (NP (NP the gene)
                                (SBAR (WHNP-1 that) 
				      (S (NP-SBJ-3 *T*-1)
					 (PRN ,
					      (SBAR-ADV if
							(S (NP-SBJ-4 *-3)
							   (VP damaged
							       (NP *-4))))
					      ,)
                                         (VP flipped
                                             (NP a colon cell)
                                             (PP-CLR into
						     (NP full-blown malignancy))))))))))))
     .))
( (S (NP-SBJ They)
     (VP focused
         (PP-CLR on
		 (NP chromosome 17)))
     .))
( (S (PP-TMP For
	     (NP months))
     (NP-SBJ-1 the Johns Hopkins researchers)
     ,
     (S-MNR (NP-SBJ *-1)
	    (VP using
		(NP gene probes)))
     ,
     (VP (ADVP-MNR experimentally)
         crawled
         (PP-DIR down
		 (NP (NP the length)
		     (PP of
			 (NP chromosome 17))))
	 ,
	 (S-ADV (NP-SBJ *-1)
		(VP looking
		    (PP-CLR for
			    (NP (NP the smallest common bit)
				(PP of
				    (NP genetic material))
				(VP lost
				    (NP *)
				    (PP-LOC in
					    (NP all tumor cells))))))))
     .))
( (S (NP-SBJ (NP Such a piece)
             (PP of
                 (NP DNA)))
     (VP would
         (ADVP probably)
         (VP constitute
             (NP a gene)))
     .))
( (S (SBAR-TMP (WHADVP-1 When)
	       (S (NP-SBJ they)
		  (VP found
		      (NP it)
		      (NP-TMP last winter)
		      (ADVP-TMP *T*-1))))
     ,
     (NP-SBJ Dr. Vogelstein)
     (VP was
         (ADJP-PRD dubious
		   (SBAR that
			 (S (NP-SBJ the search)
			    (VP was
				(ADVP-PRD over))))))
     .))
( (S (NP-SBJ His doubts)
     (VP stemmed
         (PP-CLR from
		 (NP the fact
		     (SBAR that
			   (S (ADVP-TMP (NP several years)
					earlier)
			      (NP-SBJ (NP a Princeton University researcher)
				      ,
				      (NP Arnold Levine)
				      ,)
			      (VP had
				  (VP found
				      (PP-LOC in
					      (NP (NP experiments)
						  (PP with
						      (NP mice))))
				      (SBAR that
					    (S (NP-SBJ (NP a gene)
						       (VP called
							   (S (NP-SBJ *)
							      (NP-PRD p53))))
					       (VP could
						   (VP transform
						       (NP normal cells)
						       (PP-CLR into
							       (NP cancerous ones)))))))))))))
     .))
( (S (NP-SBJ (NP The deletion)
             (SBAR (WHNP-1 0)
                   (S (NP-SBJ Dr. Vogelstein)
                      (VP found
                          (NP *T*-1)))))
     (VP was
         (PP-LOC-PRD in
		     (NP (NP exactly the same spot)
			 (PP as
			     (NP p53)))))
     .))
( (S But
     (NP-SBJ Mr. Levine)
     (VP had
	 (VP said
	     (SBAR 0
		   (S (NP-SBJ-2 the p53 gene)
		      (VP caused
			  (NP cancer)
			  (PP-MNR by
				  (S-NOM (NP-SBJ *-2)
					 (VP promoting
					     (NP growth))))
			  ,
			  (SBAR-ADV whereas
				    (S (NP-SBJ the Johns Hopkins scientists)
				       (VP were
					   (VP looking
					       (PP-CLR for
						       (NP (NP a gene)
							   (SBAR (WHNP-1 that)
								 (S (NP-SBJ *T*-1)
								    (VP suppressed
									(NP growth)))))))))))))))
     .))
( (S (S (PP Despite
            (NP that))
        ,
        (SBAR-TMP (WHADVP-1 when)
		  (S (NP-SBJ the Johns Hopkins scientists)
		     (VP compared
			 (NP (NP the gene)
			     (SBAR (WHNP-2 0)
				   (S (NP-SBJ they)
				      (VP had
					  (VP found
					      (NP *T*-2)
					      (PP-LOC in
						      (NP the human cancer cells)))))))
			 (PP-CLR with
				 (NP (NP the Mr. Levine 's)
				     p53 gene))
			 (ADVP-TMP *T*-1))))
        (NP-SBJ they)
	(VP found
	    (SBAR 0
		  (S (NP-SBJ the two)
		     (VP were
			 (ADJP-PRD identical))))))
     ;
     (S (NP-SBJ it)
        (VP turned
            (PRT out)
            (SBAR that
                  (S (PP-LOC in
			     (NP (NP Mr. Levine 's)
				 cancer studies))
                     ,
                     (NP-SBJ he)
                     (VP had
                         (ADVP-MNR unknowingly)
                         (VP been
                             (VP observing
                                 (NP (NP a damaged form)
                                     (PP of
                                         (NP (NP p53)
                                             --
                                             (NP a cancer-suppressing gene)))))))))))
     .))
( (SINV (S-TPC-1 (NP-SBJ The discovery)
		 ``
		 (VP (ADVP-MNR suddenly)
		     puts
		     (NP an obscure gene)
		     (PP-PUT (ADVP right) 
			     in
			     (NP (NP the cockpit)
				 (PP of
				     (NP cancer formation))))))
	,
	''
	(VP says
	    (SBAR 0
		  (S *T*-1)))
	(NP-SBJ (NP Robert Weinberg)
		,
		(NP (NP a leader)
		    (PP in
			(NP cancer-gene research))
		    (PP-LOC at
			    (NP (NP Whitehead Institute)
				(PP-LOC in
					(NP (NP Cambridge)
					    ,
					    (NP Mass)))))))
	.))
( (S (NP-SBJ Evidence
             (SBAR *ICH*-2))
     (ADVP-TMP now)
     (VP is
         (VP emerging
             (SBAR-2 that
                     (S (NP-SBJ the p53 suppressor gene)
                        (VP is
                            (ADJP-PRD involved
				      (PP in
					  (NP other cancers)))
                            ,
                            (ADVP too))))))
     .))
( (S (NP-SBJ (NP Researchers)
             (PP-LOC in
		     (NP (NP Edinburgh)
			 ,
			 (NP Scotland)
			 ,)))
     (VP have
         (VP found
             (SBAR that
                   (S (PP-LOC in
			      (NP (QP 23 of 38) 
				  breast tumors))
                      ,
                      (NP-SBJ-1 (NP one copy)
                                (PP of
                                    (NP chromosome 17)))
                      (VP was
                          (VP mutated
                              (NP *-1)
                              (PP-LOC at
				      (NP (NP the spot)
					  (SBAR (WHADVP-2 where)
						(S (NP-SBJ gene p53)
						   (VP lies
						       (ADVP-LOC-CLR *T*-2))))))))))))
     .))
( (S (NP-SBJ The scientists)
     (VP say
         (SBAR that
               (S (SBAR-PRP since
			    (S (NP-SBJ breast cancer)
			       (ADVP-TMP often)
			       (VP strikes
				   (NP (NP multiple members)
				       (PP of
					   (NP certain families))))))
                  ,
                  (NP-SBJ (NP the gene)
                          ,
                          (SBAR-TMP (WHADVP-1 when)
				    (S (NP-SBJ *)
				       (VP inherited
					   (PP-MNR in
						   (NP a damaged form))
					   (ADVP-TMP *T*-1))))
                          ,)
                  (VP may
                      (VP predispose
                          (NP women)
                          (PP-CLR to
				  (NP the cancer)))))))
     .))
( (S (NP-SBJ-1 The p53 gene)
     (VP has
         (ADVP just)
	 (VP been
             (VP implicated
                 (NP *-1)
                 (PP-CLR in
			 (NP lung cancer)))))
     .))
( (S (PP-LOC In
	     (NP (NP a report)
		 (ADVP-LOC out)
		 (NP-TMP last week)))
     ,
     (NP-SBJ (NP (NP John Minna)
		 and
		 (NP colleagues))
	     (PP-LOC at
		     (NP the National Cancer Institute)))
     (VP say
         (SBAR that
               (S (NP-SBJ (NP (QP about half)
			      the cells)
			  (VP taken
			      (NP *)
			      (PP-CLR from
				      (NP (NP lung cancer tissue)
					  (SBAR (WHNP-1 0)
						(S (NP-SBJ they)
						   (VP tested
						       (NP *T*-1))))))))
		  (VP are
                      (VP missing
                          (NP this gene))))))
     .))
( (S (NP-SBJ There)
     (ADVP also)
     (VP are
         (NP-PRD (NP reports)
		 (PP from
		     (NP several labs))
		 ,
		 (VP (ADVP-TMP as yet)
		     unpublished
		     (NP *))
		 ,
		 (PP of
		     (NP (NP missing p53 genes)
			 (PP-LOC in
				 (NP (NP tissue)
				     (VP taken
					 (NP *)
					 (PP-CLR from
						 (NP kidney , brain and skin cancers)))))))))
     .))
( (S (PP-TMP At
	     (NP the same time))
     ,
     (NP-SBJ-1 the Johns Hopkins team and others)
     (VP are
         (VP rushing
             (S (NP-SBJ *-1)
                (VP to
                    (VP pinpoint
                        (NP other tumor-suppressor genes))))))
     .))
( (S (NP-SBJ-1 Dr. Vogelstein)
     (VP hopes
	 (S (NP-SBJ *-1)
	    (ADVP-TMP soon)
	    (VP to
                (VP isolate
                    (NP one)
                    (PP-LOC-CLR on
				(NP (NP chromosome 18)
				    (PRN ,
					 (ADVP also)
					 (ADJP involved
					       (PP in
						   (NP colon cancer))))))))))
     .))
( (S (NP-SBJ-1 (NP (NP Ray White)
		   (PP-LOC in
			   (NP Utah)))
	       and
	       (NP (NP Walter Bodmer)
		   ,
		   (NP (NP a researcher)
		       (PP-LOC in
			       (NP Great Britain)))
		   ,))
     (VP are
         (ADVP-LOC-PRD close
		       (PP to
			   (S-NOM (NP-SBJ *-1)
				  (VP finding
				      (NP (NP (NP another gene)
					      (ADJP involved
						    (PP with
							(NP (NP some types)
							    (PP of
								(NP colon cancer)))))
					      ,
					      (VP thought
						  (S (NP-SBJ *)
						     (VP to
							 (VP be
							     (PP-PRD on
								     (NP chromosome 5)))))))))))))
     .))
( (S (NP-SBJ Dr. Minna)
     (VP believes
         (SBAR 0
               (S (NP-SBJ (NP people)
                          (SBAR (WHNP-1 who)
                                (S (NP-SBJ *T*-1)
                                   (VP inherit
                                       (NP (NP a defective gene)
                                           (PP-LOC somewhere on 
						   (NP (NP one)
						       (PP of
							   (NP (NP their two copies)
							       (PP of
								   (NP chromosome 3)))))))))))
                  (VP are
                      (ADJP-PRD especially prone
				(PP to
				    (NP lung cancer)))))))
     .))
( (S (ADVP-TMP Recently)
     ,
     (NP-SBJ (NP he)
             and
             (NP others))
     (VP reported
         (SBAR that
               (S (NP-SBJ the retinoblastoma suppressor gene)
                  (VP may
                      (ADVP also)
                      (VP be
                          (ADJP-PRD involved
				    (PP in
					(NP (NP some lung cancers)
					    ,
					    (CONJP as well as)
					    (NP several other (ADJP more common) cancers))))
                          ,
                          (ADVP too))))))
     .))
( (S (SBAR-TPC-2 (WHADVP-1 Where) 
		 (S (NP-SBJ these discoveries)
		    (VP will
			(VP lead
			    (ADVP-DIR *T*-1)))))
     ,
     (NP-SBJ scientists)
     (VP can
         (ADVP only)
         (VP speculate
	     (SBAR *T*-2)))
     .))
( (S (ADVP Already)
     (NP-SBJ-1 (NP two major pharmaceutical companies)
	       ,
	       (NP (NP (NP the Squibb unit)
		       (PP of
			   (NP Bristol-Myers Squibb Co.)))
		   and
		   (NP Hoffmann-La Roche Inc.))
	       ,)
     (VP are
         (VP collaborating
             (PP-CLR with
		     (NP gene hunters))
             (S-PRP (NP-SBJ *-1)
		    (VP to
			(VP turn
			    (NP (NP the anticipated cascade)
				(PP of
				    (NP discoveries)))
			    (PP-CLR into
				    (NP (NP predictive tests)
					and
					(PRN , (ADVP maybe) ,) 
					(NP new therapies))))))))
     .))
( (S (NP-SBJ Some researchers)
     (VP say
         (SBAR 0
	       (S (NP-SBJ-2 (NP new cancer drugs)
			    (SBAR (WHNP-1 0)
				  (S (NP-SBJ *T*-1)
				     (VP to
					 (VP slow
					     or
					     reverse
					     (NP tumor growth))))))
		  (VP may
		      (VP be
			  (VP based
			      (NP *-2)
			      (PP-CLR on
				      (NP (NP the suppressor proteins)
					  (VP (ADVP normally)
					      produced
					      (NP *)
					      (PP by
						  (NP-LGS the genes)))))))))))
     .))
( (S (NP-SBJ The idea)
     (VP would
         (VP be
	     (S-PRD (NP-SBJ *)
		    (VP to
			(VP administer
			    (PP-CLR to
				    (NP patients))
			    (NP (NP the growth-controlling proteins)
				(VP made
				    (NP *)
				    (PP by
					(NP-LGS (NP healthy versions)
						(PP of
						    (NP the damaged genes)))))))))))
     .))
( (S (NP-SBJ (NP It)
	     (S *EXP*-1))
     (VP may
	 (ADVP even)
	 (VP be
	     (ADJP-PRD possible)
	     (S-1 (NP-SBJ *)
		  (VP to
		      (VP replace
			  (NP defective genes)
			  (PP-CLR with
				  (NP healthy versions)))))
	     ,
	     (SBAR-ADV though
		       (S (NP-SBJ-2 no one)
			  (VP has
			      (VP come
				  (ADVP-CLR close
					    (S (NP-SBJ *-2)
					       (VP to
						   (VP doing
						       (NP that)))))
				  (ADVP-TMP so far)))))))
     .))
( (S-1 (PP In
	   (NP any case))
       (PRN ,
	    (SINV (VP says
		      (SBAR 0
			    (S *T*-1)))
		  (NP-SBJ (NP Dr. Minna)
			  (PP of
			      (NP the National Cancer Institute))))
	    ,
	    ``)
       (NP-SBJ We)
       (VP 're
	   (VP witnessing
	       (NP (NP the discovery)
		   (PP of
		       (NP (NP one)
			   (PP of
			       (NP (NP the
				       (ADJP most important)
				       steps)
				   (PP-LOC in
					   (NP (NP the genesis)
					       (PP of
						   (NP cancer)))))))))))
       .))
